Report Feature
Pruritus Therapeutic Trends and Forecast
The future of the global pruritus therapeutic market looks promising with opportunities in the hospital pharmacy, online pharmacy, and retail pharmacy markets. The global pruritus therapeutic market is expected to reach an estimated $9.2 billion by 2030 with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are increasing prevalence of skin diseases, growing old age population, and rising awareness about skin conditions.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pruritus Therapeutic by Segment
The study includes a forecast for the global pruritus therapeutic by product, disease type, distribution channel, and region.Pruritus Therapeutic Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others
Pruritus Therapeutic Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:
• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others
Pruritus Therapeutic Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
Pruritus Therapeutic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Pruritus Therapeutic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pruritus therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pruritus therapeutic companies profiled in this report include-• AbbVie
• Actavis
• Amgen
• Astellas Pharma
• Bristol-Myers Squibb
• Cara Therapeutics
• GlaxoSmithKline
• Mylan
• Novartis
• Pfizer
Pruritus Therapeutic Market Insights
Lucintel forecasts that corticosteroid will remain the largest segment over the forecast period due to the high frequency of the illness across the globe. Within this market, retail pharmacy will remain the largest segment due to the expansion of supermarket pharmacies. APAC is expected to witness the highest growth over the forecast period due to the existence of unfulfilled demands for the healthcare system and rising incidence of urticaria and atopic dermatitis.Features of the Global Pruritus Therapeutic Market
Market Size Estimates: Pruritus therapeutic market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Pruritus therapeutic market size by product, disease type, distribution channel, and region in terms of value ($B). Regional Analysis: Pruritus therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, disease types, distribution channels, and regions for the pruritus therapeutic market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pruritus therapeutic market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.FAQ
Q1. What is the pruritus therapeutic market size? Answer: The global pruritus therapeutic market is expected to reach an estimated $9.2 billion by 2030. Q2. What is the growth forecast for pruritus therapeutic market? Answer: The global pruritus therapeutic market is expected to grow with a CAGR of 3.4% from 2024 to 2030. Q3. What are the major drivers influencing the growth of the pruritus therapeutic market? Answer: The major drivers for this market are increasing prevalence of skin diseases, growing old age population, and rising awareness about skin conditions. Q4. What are the major segments for pruritus therapeutic market? Answer: The future of the pruritus therapeutic market looks promising with opportunities in the hospital pharmacy, online pharmacy, and retail pharmacy markets. Q5. Who are the key pruritus therapeutic market companies? Answer: Some of the key pruritus therapeutic companies are as follows:• AbbVie
• Actavis
• Amgen
• Astellas Pharma
• Bristol-Myers Squibb
• Cara Therapeutics
• GlaxoSmithKline
• Mylan
• Novartis
• Pfizer Q6. Which pruritus therapeutic market segment will be the largest in future? Answer: Lucintel forecasts that corticosteroid will remain the largest segment over the forecast period due to the high frequency of the illness across the globe. Q7. In pruritus therapeutic market, which region is expected to be the largest in next 5 years? Answer: APAC is expected to witness the highest growth over the forecast period due to the existence of unfulfilled demands for the healthcare system and rising incidence of urticaria and atopic dermatitis. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.
Table of Contents
1. Executive Summary
6.2 Emerging Trends in the Global Pruritus Therapeutic Market
4.1 Global Pruritus Therapeutic Market by Region
4.2.1 North American Pruritus Therapeutic Market by Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others
4.2.2 North American Pruritus Therapeutic Market by Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies
4.3.1 European Pruritus Therapeutic Market by Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others
4.3.2 European Pruritus Therapeutic Market by Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies
4.4.1 APAC Pruritus Therapeutic Market by Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others
4.4.2 APAC Pruritus Therapeutic Market by Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies
6.1.1 Growth Opportunities for the Global Pruritus Therapeutic Market by Product
6.1.2 Growth Opportunities for the Global Pruritus Therapeutic Market by Disease Type
6.1.3 Growth Opportunities for the Global Pruritus Therapeutic Market by Distribution Channel
6.1.4 Growth Opportunities for the Global Pruritus Therapeutic Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the pruritus therapeutic market by product (corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressant, calcineurin inhibitors, and others), disease type (atopic dermatitis, allergic contact dermatitis, urticaria, and others), distribution channel (hospital pharmacies, online pharmacies, and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Pruritus Therapeutic Market, Pruritus Therapeutic Market Size, Pruritus Therapeutic Market Growth, Pruritus Therapeutic Market Analysis, Pruritus Therapeutic Market Report, Pruritus Therapeutic Market Share, Pruritus Therapeutic Market Trends, Pruritus Therapeutic Market Forecast, Pruritus Therapeutic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
